Related Experiment Video
Updated: May 1, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
The E3 ligase RNF185 negatively regulates osteogenic differentiation by targeting Dvl2 for degradation
Ying Zhou1, Hanqiao Shang2, Chunli Zhang1
1Institute of Orthopaedics, The First Affiliated Hospital of Chinese PLA General Hospital, No. 51 Fucheng Road, Beijing 100048, China.
Abstract:
Osteoblast plays a pivotal role in bone metabolism and bone remodeling by mediating bone formation and regulating the activity of osteoclast. Clarifying the regulators and regulation mechanisms of osteogenic differentiation of mesenchymal stem cells (MSCs) and pre-osteoblasts will provide tremendous promise for bone repair and bone regeneration. RNF185 was identified as a candidate of endogenous suppressors of osteogenic specification in human mesenchymal stem cells (hMSCs). Here we show that RNF185 down regulates osteogenic differentiation of mouse calvaria-derived MC3T3-E1 cells, confirmed by quantitative real-time-PCR (qRT-PCR) and alkaline phosphatase (ALP) activity. Further we confirm that RNF185 interacts with dishevelled2 (Dvl2), a key mediator of Wnt signaling pathway. Overexpression of RNF185 decreases the exogenous and endogenous level of Dvl2, promotes the ubiquitination and degradation of Dvl2 and inhibits Wnt signaling, which is evident from the down-regulation of β-catenin mediated transcriptional activity. And Dvl2 reverses the effect of RNF185 on osteogenic differentiation of MC3T3-E1 cells. Taken together, our results indicate that RNF185 negatively regulates osteogenesis through the degradation of Dvl2 and down-regulation of canonical Wnt signaling pathway and suggest a possible therapeutic target in osteoporosis.
Insights
RNF185 suppresses osteogenic differentiation by degrading Dvl2 and inhibiting the Wnt signaling pathway. This finding offers a potential therapeutic target for osteoporosis and bone regeneration.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Osteoblasts are crucial for bone metabolism and remodeling.
- Understanding osteogenic differentiation regulators is key for bone repair.
- RNF185 is implicated as an endogenous suppressor of osteogenic specification.
Purpose of the Study:
- To investigate the role of RNF185 in osteogenic differentiation.
- To elucidate the molecular mechanisms by which RNF185 regulates osteogenesis.
- To identify potential therapeutic targets for bone regeneration.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess gene expression.
- Alkaline phosphatase (ALP) activity assays to measure osteogenic differentiation.
- Western blotting and co-immunoprecipitation to study protein interactions and degradation.
- Overexpression and rescue experiments in MC3T3-E1 cells.
Main Results:
- RNF185 down-regulates osteogenic differentiation in MC3T3-E1 cells.
- RNF185 interacts with dishevelled2 (Dvl2), promoting its ubiquitination and degradation.
- RNF185 inhibits the canonical Wnt signaling pathway by reducing β-catenin activity.
- Dvl2 overexpression reverses the inhibitory effects of RNF185 on osteogenesis.
Conclusions:
- RNF185 negatively regulates osteogenesis via Dvl2 degradation and Wnt/β-catenin pathway inhibition.
- RNF185 serves as a novel negative regulator of osteogenic differentiation.
- RNF185 represents a potential therapeutic target for osteoporosis and bone regeneration strategies.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting

